---
category: news
title: "Stratipath receives CE mark for breast cancer prognostic AI"
excerpt: "Stratipath AB gained CE-IVD mark for its artificial intelligence (AI)-based software for prognostic risk stratification of breast cancers, clearing the path for introduction of the solution in the EU."
publishedDateTime: 2022-06-09T22:35:00Z
originalUrl: "https://www.bioworld.com/articles/519585-stratipath-receives-ce-mark-for-breast-cancer-prognostic-ai"
webUrl: "https://www.bioworld.com/articles/519585-stratipath-receives-ce-mark-for-breast-cancer-prognostic-ai"
type: article
quality: 37
heat: 37
published: false

provider:
  name: BioWorld
  domain: bioworld.com

topics:
  - AI

images:
  - url: "https://www.bioworld.com/ext/resources/Stock-images/Therapeutic-topics/Cancer/Breast-cancer-awareness.png?height=635&t=1607544718&width=1200"
    width: 847
    height: 635
    isCached: true

secured: "ALzTUcargnq3Qudl3mvl+KY1a8qISG1qNd/kXRDqnpEJyxmEniU7nFmSSLkWuBC2kPf9pr7ooSQG0oHUgv6RFFt+CZv5rHnUOXfB8UQeEQBF6MhOfkhue1i4Ghph3nVFGsrbwbfpa6J2RIDXJKh0bJ186QSHIzj8++yUxUvPfWOwAiDumXN6+YI8Vp8XrHDpih3DCTyU4qMkuRONG6S2ZGcSbBffh3Bh2YlUkzQ/EbDZSt76BmdJnG9h4gaNPE/qaPTLUkAYezqHUjyunfjwuPSY2L7jGwoes6i/NH82V5tpx5TMw7Kd9v5+I0xDq6p+nGy1C9iLV7rXTk/gODgCfgDIMqGO+D4/5InWaZsUkGc=;LHK4z/r3Nn/gUMehgY9Cvg=="
---

